Literature DB >> 30637602

Gay and Bisexual Men's Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study.

Christian Grov1,2, Anthony W P Flynn3, Alexa B D'Angelo4,5, Javier Lopez-Rios4, David W Pantalone6, Ian W Holloway7, Jeffrey T Parsons8.   

Abstract

Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM use. We conducted one-on-one, semi-structured interviews with GBM taking PrEP in 2015-2016 (n = 103). Using thematic analysis, we identified six adherence strategies, with most participants (84.3%) utilizing multiple strategies to maintain adequate adherence: (1) integrating PrEP into part of a daily routine, (2) using a pillbox, (3) cognitive strategies/visual cues, (4) setting recurring smartphone alarms or reminders, (5) keeping medication on oneself at all times, and (6) partner or peer support for reminders and/or pill sharing. Overall, participants reported high PrEP adherence (M = 1.6 missed doses in the prior 30 days), though nearly all described missing at least one dose unintentionally in the past. Participants credited their high levels of adherence in part to the strategies they adopted. Providers working with GBM prescribed PrEP, especially patients reporting difficulties with adherence, might consider recommending any or all of the six strategies described in this study.

Entities:  

Keywords:  Adherence; Gay and bisexual men; HIV; Pre-exposure prophylaxis (PrEP); Qualitative data

Mesh:

Year:  2019        PMID: 30637602      PMCID: PMC6438208          DOI: 10.1007/s11121-019-0985-y

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  41 in total

1.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

2.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Authors:  Jean-Michel Molina; Catherine Capitant; Bruno Spire; Gilles Pialoux; Laurent Cotte; Isabelle Charreau; Cecile Tremblay; Jean-Marie Le Gall; Eric Cua; Armelle Pasquet; François Raffi; Claire Pintado; Christian Chidiac; Julie Chas; Pierre Charbonneau; Constance Delaugerre; Marie Suzan-Monti; Benedicte Loze; Julien Fonsart; Gilles Peytavin; Antoine Cheret; Julie Timsit; Gabriel Girard; Nicolas Lorente; Marie Préau; James F Rooney; Mark A Wainberg; David Thompson; Willy Rozenbaum; Veronique Doré; Lucie Marchand; Marie-Christine Simon; Nicolas Etien; Jean-Pierre Aboulker; Laurence Meyer; Jean-François Delfraissy
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

3.  Tailored text messaging intervention for HIV adherence: a proof-of-concept study.

Authors:  Megan A Lewis; Jennifer D Uhrig; Carla M Bann; Jennie L Harris; Robert D Furberg; Curtis Coomes; Lisa M Kuhns
Journal:  Health Psychol       Date:  2012-04-30       Impact factor: 4.267

Review 4.  Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis.

Authors:  Douglas S Krakower; Sachin Jain; Kenneth H Mayer
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 5.  Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.

Authors:  Jessica E Haberer
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

Review 6.  Optimizing ART adherence: update for HIV treatment and prevention.

Authors:  Reuben N Robbins; Anya Y Spector; Claude A Mellins; Robert H Remien
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

Review 7.  Interventions to improve adherence to antiretroviral therapy: a rapid systematic review.

Authors:  Krisda H Chaiyachati; Osondu Ogbuoji; Matthew Price; Amitabh B Suthar; Eyerusalem K Negussie; Till Bärnighausen
Journal:  AIDS       Date:  2014-03       Impact factor: 4.177

8.  Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention.

Authors:  Rupa R Patel; Leandro Mena; Amy Nunn; Timothy McBride; Laura C Harrison; Catherine E Oldenburg; Jingxia Liu; Kenneth H Mayer; Philip A Chan
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.

Authors:  Michael L Scanlon; Rachel C Vreeman
Journal:  HIV AIDS (Auckl)       Date:  2013-01-07

Review 10.  Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps.

Authors:  Fabienne Boeni; Esther Spinatsch; Katja Suter; Kurt E Hersberger; Isabelle Arnet
Journal:  Syst Rev       Date:  2014-03-24
View more
  2 in total

1.  Socio-behavioral factors related to PrEP non-adherence among gay male PrEP users living in California and New York: A behavioral theory informed approach.

Authors:  Minhao Dai; Christopher Calabrese
Journal:  J Behav Med       Date:  2022-01-06

2.  Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials.

Authors:  Gilbert Lazarus; Vincent Kharisma Wangsaputra; Melva Louisa; Vivian Soetikno; Raph L Hamers
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.